Jonathan Kanter — top U.S. antitrust enforcer and head of Antitrust Division — announces new task force targeting health care monopolies in interview with #PostLive .

KANTER: We’re seeing health care insurance companies buying up, at an extraordinary clip, health care providers…

This…

Will generative AI really move the needle in drug development? STAT's Casey Ross will talk to Kimberly Powell of NVIDIA #STATBreakthrough

Get a closer look at Google DeepMind's AI system AlphaFold with Colin Murdoch and Casey Ross #STATBreakthrough

Thanks to all who supported these works — our sources; experts who gave time and insight; aggrieved families who shared stories through gnashed teeth; incredible editors and artists. That it achieved this honor is a tribute to all of you. Let’s go! statnews.com/denied-by-ai-u…

New from Casey Ross: Google unveiled AlphaFold 3 on Wednesday, which can predict the structure of proteins and interactions with RNA, DNA, ions, and other small molecules.

statnews.com/2024/05/08/dru…

You can also hear more about AlphaFold at STAT's Breakthrough Summit next week!

The release of AlphaFold 3 by Google DeepMind and Isomorphic Labs is a big leap in the prediction of a wider universe of biomolecules.

But, its usefulness for drug discovery, and impact on trial failure rates, is a big open question.

statnews.com/2024/05/08/dru… via STAT

Huzzah!

So thrilled to be named a Pulitzer finalist with Bob Herman for investigative reporting for our series exposing the use of #AI to deny care to desperately ill patients in Medicare Advantage.

Thanks especially to the sources who had the courage to tell us their stories!

On this episode Katherine Eban discusses her two-year investigation into brain tissue research at Mount Sinai. Also, Adam Feuerstein ✡️ Allison DeAngelis welcome STAT's new biotech reporter, Elaine Chen

If you love STAT, it's a good week to subscribe. We just launched a new paywall. Readers get 3 'free' stories. STAT+ exclusives will remain subscriber-only.

Best deal: $30 for 3 mos. Support high-quality journalism, which isn't cheap to produce! statnews.com

If #AI can really improve productivity, and reduce clinician burnout, shouldn’t it be accessible to all caregivers — and not just those who work in academic medical centers?

Via STAT:

statnews.com/2024/04/29/hea… via STAT

In the long-term, generative AI is likely to be a huge help with clinical documentation.

BUT, several recent studies have found there are plenty of kinks to work out in the short term.

Via STAT:

statnews.com/2024/04/25/hea… via STAT

I'm beyond thrilled (!!!) to be named winner of The Batten Medal with Bob Herman for our investigative series on the use of AI to deny care within Medicare Advantage.

I spent formative years in JO reading the works honored in this contest. So cool!

poynter.org/news-release/2…

I really enjoyed this conversation with NPR's Marketplace on our investigation into the use of an algorithm to deny care to Medicare Advantage patients.

marketplace.org/shows/marketpl…

Original story with Bob Herman via STAT: bit.ly/4b1WM75

Microsoft is moving fast to develop and sell AI in health care. It has also organized four separate coalitions to devise standards and guardrails for its use.

How will this end?

Story with Brittany Trang, via STAT:

statnews.com/2024/04/18/mic… via STAT

Woohoo!!! Thanks so much NIHCM for seeing the import and value of our journalism!

Lots of the proposals for fixing #healthcare #cybersecurity focus on equipping hospitals (or penalizing them if an attack occurs).

But as the Change outage shows, third-party vendors pose a huge risk to providers.

STAT' Mohana Ravindranath on what's next:
statnews.com/2024/03/29/cha…

Can’t wait to read this!

Whether 2024 is the year #biotech has been waiting for — or a continuation of the last rocky three years — Adam Feuerstein ✡️ will be there every step of the way in his new subscriber-only newsletter.

Get it in your inbox starting Thursday: trib.al/vLyBxph

BREAKING: Supreme Court mifepristone arguments focus on physicians’ right to sue, not FDA judgment statnews.com/2024/03/26/sup… via STAT Sarah Owermohle